AIR-STEMI Trial Shows Physiology-guided Complete Revascularisation Reduced Cardiovascular Events in Patients with STEMI and Multivessel Disease
Sahajanand Medical Technologies (SMT) highlighted results from AIR-STEMI, an investigator-initiated, multicentre, randomised clinical trial in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary




